Medcura, Inc.
7 private offerings reported to the SEC on Form D since 2016, $60.2M sold in all. Biotech, Maryland.
- Form D offerings: 7
- Reported sold: $60.2M
- Newest: Jul 25, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Jul 25, 2025 | — | $28.5M | $38.3M | Medcura, Inc.Biotech · Maryland | Not amended | 0000929638-25-002712 |
| Aug 16, 2022 | — | $22.5M | $22.8M | Medcura, Inc.Biotech · Maryland | Jul 24, 2024 | 0001567619-22-016358 |
| Nov 2, 2021 | — | $3.5M | $5.8M | Medcura, Inc.Biotech · Maryland | Not amended | 0001567619-21-019159 |
| Sep 28, 2020 | — | $3.0M | $5.0M | Medcura, Inc.Biotech · Maryland | Not amended | 0001567619-20-017138 |
| Jul 2, 2018 | — | $1.6M | $2.5M | gel-e, Inc.Biotech · Maryland | Not amended | 0001672180-18-000001 |
| Sep 20, 2016 | — | $1.1M | $3.1M | gel-e, Inc.Biotech · Maryland | Nov 10, 2016 | 0001672180-16-000003 |
| Apr 14, 2016 | — | $11 | $200 | Remedium Technologies, INC.Biotech · Maryland | Not amended | 0001671724-16-000001 |
- Business address
- Riverdale, MD
- Incorporated in
- Delaware
- Former names
- gel-e, Inc.; Remedium Technologies, INC.
- All SEC filings
- CIK 1672180 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR